Biosafety during a pandemic: shared resource laboratories rise to the challenge.

Biosafety has always been an important aspect of daily work in any research institution, particularly for cytometry Shared Resources Laboratories (SRLs). SRLs are common-use spaces that facilitate the sharing of knowledge, expertise, and ideas. This sharing inescapably involves contact and interacti...

Descripción completa

Detalles Bibliográficos
Autores: Aspland, Avrill M, Douagi, Iyadh, Filby, Andrew, Jellison, Evan R, Martinez Garcia, Maria Dolores, Shinko, Diana, Smith, Adrian L, Tang, Vera A, Thornton, Sherry
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/17426
Acceso en línea:http://hdl.handle.net/20.500.12105/17426
Access Level:acceso abierto
Palabra clave:COVID-19
Containment of Biohazards
Flow Cytometry
Humans
Laboratories
Risk Assessment
id ES_e2ffacbc4614f3b79ecb43d6793f1fa4
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/17426
network_acronym_str ES
network_name_str España
repository_id_str
spelling Biosafety during a pandemic: shared resource laboratories rise to the challenge.Aspland, Avrill MDouagi, IyadhFilby, AndrewJellison, Evan RMartinez Garcia, Maria DoloresShinko, DianaSmith, Adrian LTang, Vera AThornton, SherryCOVID-19Containment of BiohazardsFlow CytometryHumansLaboratoriesRisk AssessmentBiosafety has always been an important aspect of daily work in any research institution, particularly for cytometry Shared Resources Laboratories (SRLs). SRLs are common-use spaces that facilitate the sharing of knowledge, expertise, and ideas. This sharing inescapably involves contact and interaction of all those within this working environment on a daily basis. The current pandemic caused by SARS-CoV-2 has prompted the re-evaluation of many policies governing the operations of SRLs. Here we identify and review the unique challenges SRLs face in maintaining biosafety standards, highlighting the potential risks associated with not only cytometry instrumentation and samples, but also the people working with them. We propose possible solutions to safety issues raised by the COVID-19 pandemic and provide tools for facilities to adapt to evolving guidelines and future challenges.WileyNIH - National Cancer Institute (NCI) (Estados Unidos)20242024-02-0220212021-01-0120212021-01-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/17426reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/174262026-06-12T12:43:37Z
dc.title.none.fl_str_mv Biosafety during a pandemic: shared resource laboratories rise to the challenge.
title Biosafety during a pandemic: shared resource laboratories rise to the challenge.
spellingShingle Biosafety during a pandemic: shared resource laboratories rise to the challenge.
Aspland, Avrill M
COVID-19
Containment of Biohazards
Flow Cytometry
Humans
Laboratories
Risk Assessment
title_short Biosafety during a pandemic: shared resource laboratories rise to the challenge.
title_full Biosafety during a pandemic: shared resource laboratories rise to the challenge.
title_fullStr Biosafety during a pandemic: shared resource laboratories rise to the challenge.
title_full_unstemmed Biosafety during a pandemic: shared resource laboratories rise to the challenge.
title_sort Biosafety during a pandemic: shared resource laboratories rise to the challenge.
dc.creator.none.fl_str_mv Aspland, Avrill M
Douagi, Iyadh
Filby, Andrew
Jellison, Evan R
Martinez Garcia, Maria Dolores
Shinko, Diana
Smith, Adrian L
Tang, Vera A
Thornton, Sherry
author Aspland, Avrill M
author_facet Aspland, Avrill M
Douagi, Iyadh
Filby, Andrew
Jellison, Evan R
Martinez Garcia, Maria Dolores
Shinko, Diana
Smith, Adrian L
Tang, Vera A
Thornton, Sherry
author_role author
author2 Douagi, Iyadh
Filby, Andrew
Jellison, Evan R
Martinez Garcia, Maria Dolores
Shinko, Diana
Smith, Adrian L
Tang, Vera A
Thornton, Sherry
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NIH - National Cancer Institute (NCI) (Estados Unidos)
dc.subject.none.fl_str_mv COVID-19
Containment of Biohazards
Flow Cytometry
Humans
Laboratories
Risk Assessment
topic COVID-19
Containment of Biohazards
Flow Cytometry
Humans
Laboratories
Risk Assessment
description Biosafety has always been an important aspect of daily work in any research institution, particularly for cytometry Shared Resources Laboratories (SRLs). SRLs are common-use spaces that facilitate the sharing of knowledge, expertise, and ideas. This sharing inescapably involves contact and interaction of all those within this working environment on a daily basis. The current pandemic caused by SARS-CoV-2 has prompted the re-evaluation of many policies governing the operations of SRLs. Here we identify and review the unique challenges SRLs face in maintaining biosafety standards, highlighting the potential risks associated with not only cytometry instrumentation and samples, but also the people working with them. We propose possible solutions to safety issues raised by the COVID-19 pandemic and provide tools for facilities to adapt to evolving guidelines and future challenges.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01
2021
2021-01-01
2024
2024-02-02
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/17426
url http://hdl.handle.net/20.500.12105/17426
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869422461754277888
score 15,812455

Similares en LA Referencia